(Q54457003)

30 May 2018

title

Pharmacology of mitoxantrone: mode of action and pharmacokinetics. (English)

1 reference

30 May 2018

1 reference

1 reference

1

D S Alberts

1 reference

30 May 2018

author name string

Y M Peng

2

1 reference

30 May 2018

G T Bowden

3

1 reference

30 May 2018

W S Dalton

4

1 reference

30 May 2018

C Mackel

5

1 reference

30 May 2018

publication date

1 January 1985

1 reference

30 May 2018

Investigational New Drugs

published in

1 reference

30 May 2018

volume

3

1 reference

30 May 2018

issue

2

1 reference

30 May 2018

page(s)

101-107

1 reference

30 May 2018

Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy

cites work

1 reference

12 December 2020

Disposition of mitoxantrone in patients

1 reference

12 December 2020

Mechanism of DNA-binding of some aminoalkylamino-derivatives of anthraquinone and naphthacenequinone

1 reference

12 December 2020

Mitoxantrone: a phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours

1 reference

12 December 2020

Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast Cancer

1 reference

12 December 2020

DNA-binding specificity and RNA polymerase inhibitory activity of bis(aminoalkyl)anthraquinones and bis(methylthio)vinylquinolinium iodides

1 reference

12 December 2020

Dependence of mammalian DNA replication on DNA supercoling I. Effects of ethidium bromide on DNA synthesis in permeable Chinese hamster ovary cells

1 reference

12 December 2020

Mitoxantrone hydrochloride (NSC-310739) in lymphoma. A Southwest Oncology Group study

1 reference

12 December 2020

Molecular and biochemical pharmacology of mitoxantrone

1 reference

12 December 2020

Molecular pharmacology of the anthracycline drug 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (Cl 216,942).

1 reference

12 December 2020

Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide

1 reference

12 December 2020

X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution

1 reference

12 December 2020

Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids

1 reference

12 December 2020

Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II

1 reference

12 December 2020

Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone

1 reference

12 December 2020

Mitoxantrone metabolism in the isolated perfused rat liver

1 reference

12 December 2020

Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedione

1 reference

12 December 2020

Pharmacology of mitoxantrone in cancer patients

1 reference

12 December 2020

AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS.

1 reference

12 December 2020

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00174156

0 references

1 reference

30 May 2018